Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan.

Hadjiyianni, Irene; Desai, Urvi; Suzuki, Shuichi; Ivanova, Jasmina I; Cao, Dachuang; Kirson, Noam Y; Chida, Dai; Enloe, Caroline; Birnbaum, Howard G; Perez-Nieves, Magaly

Hadjiyianni, Irene; Desai, Urvi; Suzuki, Shuichi; Ivanova, Jasmina I; Cao, Dachuang; Kirson, Noam Y; Chida, Dai; Enloe, Caroline; Birnbaum, Howard G; Perez-Nieves, Magaly.

Afiliación

Hadjiyianni I; Lilly Deutschland GmBH, Bad Homburg, Germany.
Desai U; Analysis Group, Inc., Boston, MA, USA. urvi.desai@analysisgroup.com.
Suzuki S; Eli Lilly Japan, K.K., Kobe, Japan.
Ivanova JI; Analysis Group, Inc., New York, NY, USA.
Cao D; Eli Lilly and Company, Indianapolis, IN, USA.
Kirson NY; Analysis Group, Inc., Boston, MA, USA.
Chida D; Eli Lilly Japan, K.K., Kobe, Japan.
Enloe C; Analysis Group, Inc., Boston, MA, USA.
Birnbaum HG; Analysis Group, Inc., Boston, MA, USA.
Perez-Nieves M; Eli Lilly and Company, Indianapolis, IN, USA.

Diabetes Ther ; 8(1): 149-166, 2017 Feb.

Article en En | MEDLINE | ID: mdl-27913984

Palabras clave

Basal insulin; Costs; Factors; Persistence; Resource use; Type 2 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Ther Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google